Corporate

You heard it here first.

 
 
 

Our news

Bringing you the latest!

Corporate

MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin

Corporate - Investors

6 April 2020

 
 

CONTACT

  • This field is for validation purposes and should be left unchanged.